STRATA Skin Sciences, Inc. announced the expansion of a direct distribution agreement with Kosmo Meditech, which is now assigned to Kosmo's corporate parent, Cutech Inc., effective as of January 1, 2024, for a combination of direct capital sales and direct recurring revenue sales in Korea. The key highlights of this amendment, which reinforce STRATA's commitment to innovation and customer satisfaction, include: Extended term through December 31, 2026, ensuring a prolonged and stable partnership Established defined annual and quarterly performance-based purchase requirements, including STRATA becoming sole provider of gas and consumables, securing a consistent demand for STRATA's products, providing a reliable forecast for production and inventory management, and ensuring stronger top-line revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3857 USD | -2.00% | +0.36% | -29.89% |
May. 15 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
May. 15 | Earnings Flash (SSKN) STRATA SKIN SCIENCES Reports Q1 Revenue $6.8M, vs. Street Est of $6.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.89% | 13.52M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.42% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- SSKN Stock
- News STRATA Skin Sciences, Inc.
- STRATA Skin Sciences, Inc. Announces Expansion of Distribution Agreement with Kosmo Meditech